Literature DB >> 1424746

Anti-endothelial cell antibodies in retinal vasculitis.

C Edelsten1, D D'Cruz, G R Hughes, E M Graham.   

Abstract

Auto-antibodies to endothelial cells are found in a variety of vasculitic disorders including two diseases associated with retinal vasculitis: Behcet's disease and multiple sclerosis. In this study we have examined the prevalence of anti-endothelial cell antibodies [AECA] in 15 patients with retinal vasculitis [RV] associated with Behcet's disease, multiple sclerosis or sarcoidosis and 20 patients with idiopathic retinal vasculitis. 47% of patients with RV associated with systemic disease and 35% of patients with idiopathic RV had AECA, compared to 1% of 70 normal controls. The mean levels of AECA were similar in both groups of patients, and comparable to levels found in other systemic vasculitides.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424746     DOI: 10.3109/02713689208999534

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  5 in total

Review 1.  Antiendothelial cell antibodies (AECA) in patients with uveoretinitis.

Authors:  C Edelsten; D P D'Cruz
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 2.  Anti-endothelial cell antibodies and autoimmune diseases.

Authors:  N Del Papa; D Gambini; P L Meroni
Journal:  Clin Rev Allergy       Date:  1994

3.  Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis.

Authors:  A G Zaman; C Edelsten; M R Stanford; E M Graham; B A Ellis; H Direskeneli; D P D'Cruz; G R Hughes; D C Dumonde; G R Wallace
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

4.  Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease.

Authors:  H Direskeneli; G Keser; D D'Cruz; M A Khamashta; T Akoğlu; H Yazici; S Yurdakul; V Hamuryudan; S Ozgün; A J Goral
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

Review 5.  Antiphospholipid antibodies: paradigm in transition.

Authors:  Lawrence L Horstman; Wenche Jy; Carlos J Bidot; Yeon S Ahn; Roger E Kelley; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; Seyed Ali Mousavi; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2009-01-20       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.